Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coversin in PNH with Eculizumab Resistance
NCT03427060Phase 2Completed
- Sponsor
- Akari Therapeutics
- Start
- May 2018
- Primary completion
- Nov 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of nomacopan in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Akari Therapeutics. Started May 2018; status: completed.
02
Drugs
nomacopan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT03427060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03427060.